Want to read (11)
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, Powderly JD, Carvajal RD, Sosman JA, Atkins MB, Leming PD, Spigel DR, Antonia SJ, Horn L, Drake CG, Pardoll DM, Chen L, Sharfman WH, Anders RA, Taube JM, McMiller TL, Xu H, Korman AJ, Jure-Kunkel M, Agrawal S, McDonald D, Kollia GD, Gupta A, Wigginton JM, Sznol M.
N Engl J Med · 2012
Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression
Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS, Arkin AP, Lim WA.
Cell · 2013
IL-6 in inflammation, immunity, and disease
Tanaka T, Narazaki M, Kishimoto T.
Cold Spring Harb Perspect Biol · 2014
Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells
Meyers RM, Bryan JG, McFarland JM, Weir BA, Sizemore AE, Xu H, Dharia NV, Montgomery PG, Cowley GS, Pantel S, Goodale A, Lee Y, Ali LD, Jiang G, Lubonja R, Harrington WF, Strickland M, Wu T, Hawes DC, Zhivich VA, Wyatt MR, Kalani Z, Chang JJ, Okamoto M, Stegmaier K, Golub TR, Boehm JS, Vazquez F, Root DE, Hahn WC, Tsherniak A.
Nat Genet · 2017
Long COVID: major findings, mechanisms and recommendations
Davis HE, McCorkell L, Vogel JM, Topol EJ.
Nat Rev Microbiol · 2023
Wnt signaling in cancer
Zhan T, Rindtorff N, Boutros M.
Oncogene · 2017
Understanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI, Ostrand-Rosenberg S, Hedrick CC, Vonderheide RH, Pittet MJ, Jain RK, Zou W, Howcroft TK, Woodhouse EC, Weinberg RA, Krummel MF.
Nat Med · 2018
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Öhlund D, Handly-Santana A, Biffi G, Elyada E, Almeida AS, Ponz-Sarvise M, Corbo V, Oni TE, Hearn SA, Lee EJ, Chio II, Hwang CI, Tiriac H, Baker LA, Engle DD, Feig C, Kultti A, Egeblad M, Fearon DT, Crawford JM, Clevers H, Park Y, Tuveson DA.
J Exp Med · 2017
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG.
Science · 2003
Mechanisms underlying inflammation in neurodegeneration
Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH.
Cell · 2010
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA.
Science · 1993